companydata.dkcompanydata.dk

GxMed Nordic ApS: Financial statements 2022

CVR: 37089842

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

GxMed Nordic ApS (CVR 37089842) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024. The solvency ratio was 46.6%.

Gross Profit
DKK -144,834
Profit/Loss
DKK -117,961
Equity
DKK 1,488,024
Total Assets
DKK 3,193,944

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--145K-118K1.5M-
2021-572K1.1M1.6M3
2020-4.6M2.3M550K3
2018-2.6M-442K421K2
2017--506K-1.1M863K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GxMed Nordic ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About GxMed Nordic ApS

GxMed Nordic ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GxMed Nordic IVS. The company is owned by HHR HOLDING A/S. The company has 1 employee (2020). In 2022, the company reported a gross profit of DKK -144,834 and a net result of DKK -117,961 compared with DKK 1,056,263 the year before. Equity in the 2022 report amounted to DKK 1,488,024.

Source: annual report 2022, Danish Business Authority

Other financial years